Cimaas logo Cimaas logo
  • About
    • Mission
    • CiMaas Team
    • Supervisory Board
    • Scientific Advisory Board
    • New therapeutic concepts
    • News archive
    • Careers
    • Collaborations
  • Technology
    • Technology
    • Dendritic cell vaccine
    • Haploidentical NK cell therapy
    • Publications
  • Pipeline
  • Investors
  • General public
  • Contact
  • About
    • Mission
    • CiMaas Team
    • Supervisory Board
    • Scientific Advisory Board
    • New therapeutic concepts
    • News archive
    • Careers
    • Collaborations
  • Technology
    • Technology
    • Dendritic cell vaccine
    • Haploidentical NK cell therapy
    • Publications
  • Pipeline
  • Investors
  • General public
  • Contact
Collaborations

COLLABORATIONS

CiMaas has a close collaboration with several partners.

    • Brightlands
    • Neuroplast
    • UM Holding Maastricht
    • Miltenyi
    • Mercachemsyncom Weert
    • BasicPharma
    • AmpTec

Latest news
  • CiMaas receives RVO innovation credit for DC vaccine clinical trial January 9, 2021
  • Jolanda de Vries joins scientific advisory board of CiMaas September 30, 2020
  • Oncologie.nu publishes interview with CEO Gerard Bos September 21, 2020
  • CiMaas and Kiadis decided to stop collaborating on the production of Natural Killer Cells May 26, 2020
  • Gerard Bos interviewed by CELL & GENE THERAPY INSIGHTS April 8, 2020
  • Disclaimer
  • Contact
visual design by scicomvisuals.
  • About
  • Technology
  • Pipeline
  • General public